Basic carbohydrate counting and glycemia in young people with type 1 diabetes in India: A randomized controlled trial

Ambica Tandon1, Eshita Bhowmik1, Zebish Ali1

  • 1Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

Insights

Basic carbohydrate counting (BCC) did not significantly improve glycemic control in children and young adults with type 1 diabetes (T1DM). However, BCC was perceived as more acceptable and offered flexibility in food choices and insulin adjustment.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Type 1 diabetes (T1DM) management in pediatric populations requires effective nutritional strategies.
  • Glycemic control is crucial for preventing long-term complications in T1DM.
  • Nutritional education plays a vital role in self-management of T1DM.

Purpose of the Study:

  • To evaluate the impact of basic carbohydrate counting (BCC) on glycemic control in children and young adults with T1DM.
  • To assess the acceptability of BCC compared to routine nutrition education (RNE).

Main Methods:

  • A randomized controlled trial involving 92 participants (6-25 years) with T1DM.
  • Intervention groups received either BCC with personalized portion size education or RNE.
  • Glycemic control was assessed using continuous glucose monitoring and HbA1c levels over 12 weeks.

Main Results:

  • No significant difference in time-in-range was observed between BCC and RNE groups.
  • HbA1c showed a significant decrease in a subgroup of participants with higher maternal education in the BCC group.
  • The BCC group reported higher overall acceptability of the nutritional approach.

Conclusions:

  • BCC offers flexibility in food choices and perceived ease of insulin adjustment for T1DM management in young individuals.
  • While not superior to RNE in overall glycemic control, BCC may benefit specific subgroups.
  • Further research with larger cohorts is warranted to explore potential benefits in certain populations.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
176
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
549